News - Pernix Therapeutics


Current filters:

Pernix Therapeutics

Popular Filters

Pernix to sell manufacturing facility to reduce costs


US specialty pharma company Pernix Therapeutics has signed a definitive agreement to divest its Houston,…

FinancialPernix TherapeuticsPharmaceuticalProduction

Breckenridge to acquire certain Cypress assets


Privately-held US generic drugmaker Breckenridge Pharmaceutical has entered into an agreement to acquire…

Breckenridge PharmaceuticalsCypress PharmaceuticalsGenericsMergers & AcquisitionsPernix Therapeutics

Pernix Thera rescues struggling Somaxon with stock deal worth $25 million


Troubled US drugmaker Somaxon Pharmaceuticals (Nasdaq: SOMX) saw its shares leap around 85% to $2.74…

Mergers & AcquisitionsPernix TherapeuticsPharmaceuticalSilenorSomaxon Pharmaceuticals

Pernix splashes out over $100 million to buy Cypress Pharma and Hawthorn Pharma


US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire…

Cypress PharmaceuticalsFinancialGenericsHawthorn PharmaceuticalsMergers & AcquisitionsPernix TherapeuticsPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top